CS
MR

Credit Suisse’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Credit Suisse’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-318,126
Closed -$8.63M – 4485
2015
Q4 		$8.63M Buy
318,126
+194,718
+158% +$5.02M 0.01% 1240
2015
Q3 		$2.7M Sell
123,408
-392,198
-76% -$10M ﹤0.01% 2036
2015
Q2 		$14.7M Buy
515,606
+249,843
+94% +$7.28M 0.01% 1005
2015
Q1 		$7.27M Buy
265,763
+154,600
+139% +$4.26M 0.01% 1398
2014
Q4 		$2.94M Sell
111,163
-64,397
-37% -$1.89M ﹤0.01% 2212
2014
Q3 		$5.29M Sell
175,560
-20,452
-10% -$633K ﹤0.01% 1721
2014
Q2 		$6.17M Sell
196,012
-3,951
-2% -$125K 0.01% 1763
2014
Q1 		$6.47M Sell
199,963
-141,847
-41% -$4.97M 0.01% 1552
2013
Q4 		$12.4M Buy
341,810
+4,363
+1% +$170K 0.01% 1118
2013
Q3 		$13.1M Buy
337,447
+31,320
+10% +$1.26M 0.01% 977
2013
Q2 		$11.5M Buy
+306,127
New +$12.1M 0.01% 1054

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Suisse's MR Position: Q1 2016 in Review

Credit Suisse sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 318,126 shares — an estimated $8.63M sold.

Credit Suisse first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $14.7M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Credit Suisse reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Credit Suisse sold 318,126 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $8.63M.
  • Credit Suisse first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Credit Suisse's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $14.7M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Credit Suisse's 13F filing for Q1 2016, filed 16 May 2016.